Gainesville, FL, United States of America

Hector Ruben Mendez-Gomez

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hector Ruben Mendez-Gomez: Innovator in Gene Delivery Systems

Introduction

Hector Ruben Mendez-Gomez is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene delivery, particularly through his innovative work with adeno-associated viral (AAV) particles. With a total of 2 patents, Mendez-Gomez is recognized for his advancements in therapeutic delivery systems.

Latest Patents

Mendez-Gomez's latest patents include "Modified AAV capsid proteins and uses thereof" and "Engineered receptor/ligand system for delivery of therapeutic agents." The first patent focuses on variant AAV capsid proteins that enhance the ability to transduce retinal cells, making them a promising vehicle for gene delivery to the retina. The second patent addresses the challenges of delivering therapeutic and diagnostic agents across the blood-brain barrier and blood-cerebrospinal fluid barrier, proposing an engineered receptor-ligand system to improve targeted delivery.

Career Highlights

Throughout his career, Mendez-Gomez has worked with esteemed organizations such as the University of Florida Research Foundation and the UAB Research Foundation. His work has been pivotal in advancing the understanding and application of gene therapy techniques.

Collaborations

Mendez-Gomez has collaborated with notable figures in the field, including Nicholas Muzyczka and Sergei Zolotukhin. These collaborations have further enriched his research and contributed to the development of innovative solutions in gene delivery.

Conclusion

Hector Ruben Mendez-Gomez is a distinguished inventor whose work in gene delivery systems has the potential to transform therapeutic approaches. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…